How it works
Managing one of the most common childhood illnesses, Enterozyn® is a proprietary synbiotic containing the probiotic strain Bifidobacterium animalis ssp. lactis and the prebiotic inulin. Outperforming the commonly used S. Boulardii, it is a pharmacy exclusive that is clinically tested in infants and children from 2 – 60 months, and significantly reduces the duration of diarrhea.
Facts
Tests demonstrate that Enterozyn® enhances the growth and persistency of Bifidobacterium animalis ssp. lactis with inulin.
Clinical trials further validate the reduction of symptoms in children suffering from acute infectious diarrhea.
Compared to placebo, it is also shown to reduce the duration of diarrhea by 25%, the number of diarrhea stools by 34%, and the number of children suffering diarrhea by an impressive 53%. Simply put, it is highly effective against viral induced diarrhea.